World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Medicine
Italy
2026

D-Index & Metrics

Best Scientists

D-Index
209
Citations
282315
World Ranking
202
National Ranking
2

Medicine

D-Index
213
Citations
317261
World Ranking
115
National Ranking
2

Research.com Recognitions

  • 2026 - Research.com Medicine in Italy Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Medicine in Italy Leader Award
  • 2023 - Research.com Medicine in Italy Leader Award
  • 2022 - Research.com Medicine in Italy Leader Award
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Giuseppe Remuzzi is affiliated with the Mario Negri Institute for Pharmacological Research in Italy. Their research spans mainly the field of medicine, with a focus on several subfields including nephrology, infectious diseases, immunology, molecular biology, and genetics.

The core topics of their scientific work include:

  • Renal Diseases and Glomerulopathies
  • Complement system in diseases
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • Chronic Kidney Disease and Diabetes
  • Blood Pressure and Hypertension Studies
  • SARS-CoV-2 and COVID-19 Research

Remuzzi's frequent publication venues reflect the focus on nephrology and clinical research, with numerous contributions to journals such as:

  • Nephrology Dialysis Transplantation
  • The Nephron journals
  • Journal of the American Society of Nephrology
  • Kidney International Reports
  • Kidney International

The scientist has coauthored extensively with several researchers, often collaborating with:

  • Ariela Benigni
  • Piero Ruggenenti
  • Norberto Perico
  • Marina Noris
  • Annalisa Perna

Among their published papers, some notable works include:

  • "COVID-19 and Italy: what next?" (2020, The Lancet)
  • "Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis" (2021, The Lancet)
  • "Immunity, endothelial injury and complement-induced coagulopathy in COVID-19" (2020, Nature Reviews Nephrology)
  • "Podocytopathies" (2020, Nature Reviews Disease Primers)
  • "The case of complement activation in COVID-19 multiorgan impact" (2020, Kidney International)

Giuseppe Remuzzi is a member of the Association of American Physicians. Their work demonstrates a concentration on kidney-related diseases, the immune system's role in disease, and the clinical implications of COVID-19, among other topics.

Best Publications

  • Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Theo Vos;Amanuel Alemu Abajobir;Kalkidan Hassen Abate;Cristiana Abbafati

  • Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Theo Vos;Theo Vos;Theo Vos;Stephen S. Lim;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati;Kaja M. Abbas;Kaja M. Abbas;Kaja M. Abbas

  • Global, regional, and national incidence, prevalence, andyears lived with disability for 354 diseases and injuries for195 countries and territories, 1990–2017: a systematicanalysis for the Global Burden of Disease Study 2017

    Gbd Disease;Injury Incidence;Lorenzo Monasta

  • Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017

    Gregory A Roth;Gregory A Roth;Degu Abate;Kalkidan Hassen Abate;Solomon M Abay

  • EFFECTS OF LOSARTAN ON RENAL AND CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND NEPHROPATHY

    Barry M. Brenner;Mark E. Cooper;Dick De Zeeuw;William F. Keane

  • Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

    Christopher J.L. Murray;Christopher J.L. Murray;Christopher J.L. Murray;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Aleksandr Y. Aravkin;Peng Zheng;Peng Zheng;Peng Zheng;Cristiana Abbafati;Cristiana Abbafati;Cristiana Abbafati

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    Mohammad H Forouzanfar;Lily Alexander;H Ross Anderson;Victoria F Bachman

  • Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013

    Theo Vos;Ryan M. Barber;Brad Bell;Amelia Bertozzi-Villa

  • Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: A systematic analysis for the Global Burden of Disease Study 2013

    Mohsen Naghavi;Haidong Wang;Rafael Lozano;Adrian Davis

  • Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Theo Vos;Christine Allen;Megha Arora;Ryan M Barber

  • Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

    Boris Bikbov;Caroline A. Purcell;Andrew S. Levey;Mari Smith

  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

    Haidong Wang;Mohsen Naghavi;Christine Allen;Ryan M Barber

  • Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017 : a systematic analysis for the Global Burden of Disease Study 2017

    Jeffrey D. Stanaway;Ashkan Afshin;Emmanuela Gakidou;Stephen S. Lim

  • Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Mohsen Naghavi;Amanuel Alemu Abajobir;Cristiana Abbafati;Kaja M Abbas

  • Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

    Simon I Hay;Amanuel Alemu Abajobir;Kalkidan Hassen Abate;Cristiana Abbafati

  • COVID-19 and Italy: what next?

    Andrea Remuzzi;Giuseppe Remuzzi

  • Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

    Catherine Owens Johnson;Minh Nguyen;Gregory A. Roth;Emma Nichols

  • Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013

    Mohammad H. Forouzanfar;Lily Alexander;H. Ross Anderson;Victoria F. Bachman

  • Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

    Giuseppe Remuzzi

  • A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease

    Marc A Pfeffer;Emmanuel A. Burdmann;Chao Yin Chen;Mark E. Cooper

Frequent Co-Authors

Norberto Perico
Norberto Perico Mario Negri Institute for Pharmacological Research
Piero Ruggenenti
Piero Ruggenenti Mario Negri Institute for Pharmacological Research
Ariela Benigni
Ariela Benigni Mario Negri Institute for Pharmacological Research
Marina Noris
Marina Noris Mario Negri Institute for Pharmacological Research
Andrea Remuzzi
Andrea Remuzzi University of Bergamo
Carla Zoja
Carla Zoja Mario Negri Institute for Pharmacological Research
Vivekanand Jha
Vivekanand Jha George Institute for Global Health
Stein Emil Vollset
Stein Emil Vollset University of Washington
Ted R. Miller
Ted R. Miller Pacific Institute
Johan Ärnlöv
Johan Ärnlöv Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative routes or flexible learning options, online nursing degrees offer multiple career pathways. Prospective students can consider a range of programs matching various educational backgrounds and career goals.

Early-career professionals or those switching fields may explore online adn programs for non nurses, which help non-nursing majors fast-track into nursing careers. After becoming a registered nurse, many accelerate their careers by enrolling in the cheapest online rn to bsn programs, which offer cost-effective pathways to higher credentials and more job options.

Individuals with non-nursing degrees can also consider msn direct entry programs online, allowing them to earn a master's in nursing without a prior nursing background. For advanced practice and leadership, experienced nurses can pursue phd nursing programs online to enhance research or academic careers within healthcare.

Exploring these online degrees can open new doors in healthcare while offering flexibility and affordability for diverse learners.

Best Scientists Citing Giuseppe Remuzzi

Trending Scientists

Recently Published Articles